<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ehinger Y</submitter><funding>Aix-Marseille Université</funding><funding>Institut National de la Santé et de la Recherche Médicale</funding><funding>AFM-Téléthon</funding><funding>Association Française du Syndrome de Rett (AFSR)</funding><funding>Promex Stiftung Für Die Forschung</funding><funding>Rettsyndrome.org</funding><funding>CSRD VA</funding><pagination>4316</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8122273</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(9)</volume><pubmed_abstract>Mutations in the X-linked &lt;i>MECP2&lt;/i> gene are responsible for Rett syndrome (RTT), a severe neurological disorder. MECP2 is a transcriptional modulator that finely regulates the expression of many genes, specifically in the central nervous system. Several studies have functionally linked the loss of MECP2 in astrocytes to the appearance and progression of the RTT phenotype in a non-cell autonomous manner and mechanisms are still unknown. Here, we used primary astroglial cells from &lt;i>Mecp2&lt;/i>-deficient (KO) pups to identify deregulated secreted proteins. Using a differential quantitative proteomic analysis, twenty-nine proteins have been identified and four were confirmed by Western blotting with new samples as significantly deregulated. To further verify the functional relevance of the</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Analysis of Astroglial Secretomic Profile in the Mecp2-Deficient Male Mouse Model of Rett Syndrome.</pubmed_title><pmcid>PMC8122273</pmcid><funding_grant_id>1</funding_grant_id><funding_grant_id>2</funding_grant_id><funding_grant_id>(Strategic pole MNH Decrypt)</funding_grant_id><funding_grant_id>3</funding_grant_id><funding_grant_id>4</funding_grant_id><funding_grant_id>5</funding_grant_id><pubmed_authors>Cunin V</pubmed_authors><pubmed_authors>Bourgoin-Voillard S</pubmed_authors><pubmed_authors>Seve M</pubmed_authors><pubmed_authors>Borloz E</pubmed_authors><pubmed_authors>Roux JC</pubmed_authors><pubmed_authors>Borges-Correia A</pubmed_authors><pubmed_authors>Matagne V</pubmed_authors><pubmed_authors>Villard L</pubmed_authors><pubmed_authors>Ehinger Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Analysis of Astroglial Secretomic Profile in the Mecp2-Deficient Male Mouse Model of Rett Syndrome.</name><description>Mutations in the X-linked &lt;i>MECP2&lt;/i> gene are responsible for Rett syndrome (RTT), a severe neurological disorder. MECP2 is a transcriptional modulator that finely regulates the expression of many genes, specifically in the central nervous system. Several studies have functionally linked the loss of MECP2 in astrocytes to the appearance and progression of the RTT phenotype in a non-cell autonomous manner and mechanisms are still unknown. Here, we used primary astroglial cells from &lt;i>Mecp2&lt;/i>-deficient (KO) pups to identify deregulated secreted proteins. Using a differential quantitative proteomic analysis, twenty-nine proteins have been identified and four were confirmed by Western blotting with new samples as significantly deregulated. To further verify the functional relevance of the</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Apr</publication><modification>2026-04-08T09:10:23.116Z</modification><creation>2025-04-05T10:29:22.893Z</creation></dates><accession>S-EPMC8122273</accession><cross_references><pubmed>33919253</pubmed><doi>10.3390/ijms22094316</doi></cross_references></HashMap>